Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Matte Kasi, Viswanadh"'
Autor:
Kakarla Ramakrishna, Lakshmi Vineela Nalla, Dumala Naresh, Kojja Venkateswarlu, Matte Kasi Viswanadh, Buchi N. Nalluri, Guntupalli Chakravarthy, Sajusha Duguluri, Payal Singh, Sachchida Nand Rai, Ashish Kumar, Veer Singh, Santosh Kumar Singh
Publikováno v:
Diseases, Vol 11, Iss 3, p 89 (2023)
Wnt/β-catenin (WβC) signaling pathway is an important signaling pathway for the maintenance of cellular homeostasis from the embryonic developmental stages to adulthood. The canonical pathway of WβC signaling is essential for neurogenesis, cell pr
Externí odkaz:
https://doaj.org/article/06f968ca1a3e4d57b8750b42baca833b
Autor:
Datta Maroti Pawde, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, Roshan Sonkar, Narendra, Suruchi Poddar, Ankita Sanjay Burande, Abhishek Jha, Kiran Yellappa Vajanthri, Sanjeev Kumar Mahto, V.N. Azger Dustakeer, Madaswamy S. Muthu
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1616-1625 (2020)
Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatment. This work aims to develop a mannose receptor-targeted bioadhesive chitosan nanoparticles fo
Externí odkaz:
https://doaj.org/article/8111eb418b5b40a4a34a3d59680330a6
Publikováno v:
Future Virology
COVID-19 is an infectious and highly contagious disease caused by SARS-CoV-2. The immunotherapy strategy has a great potential to develop a permanent cure against COVID-19. Innate immune cells are in constant motion to scan molecular alteration to ce
Autor:
null Vikas, Hemendra Kumar Sahu, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
Publikováno v:
Nanomedicine (London, England). 17(19)
Cancer is the leading cause of mortality worldwide. Among all cancer types, lung cancer is recognized as the most lethal and highly metastatic. The application of targeted nanomedicine loaded with anticancer drugs is highly desirable for successful l
Autor:
S.K. Alla, Madaswamy S Muthu, Pratap Kollu, Nand Kishore Prasad, Matte Kasi Viswanadh, K. Neogi, A. Gangwar, S.K. Shaw, Nidhi Gupta, Rajiv Kumar Mandal, Sher Singh Meena
Publikováno v:
Ceramics International. 47:8812-8819
High resolution TEM studies revealed the spherical morphology of MxCe1-xO2 (M = Co, Fe or Ti, x = 0.05) particles with their size in the range of 8–11 nm. Raman, UV and PL spectroscopy analyses evidenced that oxygen vacancy concentration modified w
Autor:
Medapati Nikitha Lakshmi Suseela, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, Vishnu Priya, null Vikas, Aseem Setia, Ankit Kumar Malik, Patharaj Gokul, Joseph Selvin, Madaswamy S. Muthu
Publikováno v:
Journal of Chromatography A. 1695:463937
Autor:
Aseem Setia, Abhishesh Kumar Mehata, null Vikas, Ankit Kumar Malik, Matte Kasi Viswanadh, Madaswamy S. Muthu
Publikováno v:
Journal of Drug Delivery Science and Technology. 81:104295
Autor:
Sanjeev Kumar Mahto, Abhishesh Kumar Mehata, Kiran Yellappa Vajanthri, V.N. Azger Dustakeer, Matte Kasi Viswanadh, Suruchi Poddar, Roshan Sonkar, Madaswamy S Muthu, Datta Maroti Pawde, Narendra, Abhishek Jha, Ankita Sanjay Burande
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1616-1625 (2020)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
Graphical abstract Bioadhesive targeted delivery of Clofazimine against M. tuberculosis.
Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatmen
Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatmen
Autor:
Madaswamy S Muthu, Suruchi Poddar, Abhishesh Kumar Mehata, Vikas, Matte Kasi Viswanadh, Kaushik Neogi, Sanjeev Kumar Mahto, Sandeep Kumar Reddy Adena, Abhishek Jha, Vishnu Priya
Publikováno v:
Nanomedicine. 15:2345-2367
Aim: To design, optimize and evaluate docetaxel-loaded chitosan nanoparticles with (targeted) and without (nontargeted) cetuximab conjugation for the treatment of non-small-cell lung cancer (NSCLC). Materials & methods: Risk-assessment, optimization,
Autor:
Roshan Sonkar, Vishnu Priya, Narendra, Mamata Singh, Madaswamy S Muthu, Matte Kasi Viswanadh, Datta Maroti Pawde, Abhishesh Kumar Mehata, Biplob Koch
Publikováno v:
Therapeutic Delivery. 11:557-571
Aim: This work focused on the development of transferrin-conjugated theranostic liposomes consisting of docetaxel (DXL) and upconversion nanoparticles for the diagnosis and treatment of gliomas. Materials & methods: Upconversion nanoparticles and doc